Monday, October 26, 2026 · Daily editionET --:--:--

Finished

Feasibility of a New Pediatric Arm Rehabilitation Robot ChARMin

NCT02443857 · Huub van Hedel · Updated 7 May 2026

What is being tested
ChARMin; ChARMin; ChARMin; ChARMin; ChARMin; ChARMin
For
Nervous System Diseases
Kind of study
Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
Who can join
Ages 5 years to 21 years. About 63 people. The full rules are on the registry page.
Where
Switzerland
When
Starts or started 1 June 2015, ends 30 May 2025. Registered 14 May 2015.
Results
None posted yet.

In the researchers' words

The purpose of this study is to investigate the applicability and feasibility of the newly developed robot platform for upper extremity therapy ("ChARMin") in children undergoing neurorehabilitation.
ClinicalTrials.gov, NCT02443857

Sites

  • Rehabilitation Center for Children and Adolescents of the University Children's Hospital ZurichAffoltern am Albis, Switzerland